biological_process

Neuronal Dysfunction

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Neuronal Dysfunction: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

35Connections

0Hypotheses

10Analyses

2Outgoing

33Incoming

0Experiments

12Debates

No summary available yet.

View on Wiki →

No AI portrait yet

🧬 Biological Process Info

Name	Neuronal Dysfunction
Key Genes/Proteins	ALPHA-SYNUCLEIN, LCN2, MAPT, MISFOLDED PROTEINS
Related Diseases	Astrocyte A1-like Polarization, Mood Disorders
Related Pathways	Downregulation Of LIMK1-Cofilin Axis

Pathway Diagram

graph TD
    Neuronal_Dysfunction["Neuronal Dysfunction"] -->|"associated"| Amyloid_beta_Pathology["Amyloid-beta Pathology"]
    style Amyloid_beta_Pathology fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
    MAPT["MAPT"] -->|"causes"| Neuronal_Dysfunction["Neuronal Dysfunction"]
    style MAPT fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
    Downregulation_Of_LIMK1_Cofili["Downregulation Of LIMK1-Cofilin Axis"] -->|"contributes to"| Neuronal_Dysfunction["Neuronal Dysfunction"]
    style Downregulation_Of_LIMK1_Cofili fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
    Phosphorylated_Tau["Phosphorylated Tau"] -->|"causes"| Neuronal_Dysfunction["Neuronal Dysfunction"]
    style Phosphorylated_Tau fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
    A1_like_Astrocytes["A1-like Astrocytes"] -->|"causes"| Neuronal_Dysfunction["Neuronal Dysfunction"]
    style A1_like_Astrocytes fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
    Inflammatory_Processes["Inflammatory Processes"] -->|"causes"| Neuronal_Dysfunction["Neuronal Dysfunction"]
    style Inflammatory_Processes fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
    style Neuronal_Dysfunction fill:#5d4400,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0,font-weight:bold

Outgoing (2)

Target	Relation	Type	Str
Mood Disorders	causes	disease	0.85
Amyloid-beta Pathology	associated_with	process	0.80

Incoming (33)

Source	Relation	Type	Str
LCN2	causes	gene	0.95
MAPT	causes	protein	0.95
Tau aggregation	promotes	process	0.92
Mutant huntingtin aggregation	causes	mechanism	0.90
Mitochondrial Impairment	causes	process	0.90
Phosphorylated Tau	causes	protein	0.90
Downregulation Of LIMK1-Cofilin Axis	contributes_to	mechanism	0.90
Amyloid-Beta Peptide	causes	compound	0.90
A1-like Astrocytes	causes	cell_type	0.89
Impaired Autophagy	causes	process	0.85
Tau Phosphorylation Dysregulation	causes	mechanism	0.85
Astrocyte A1-like Polarization	causes	phenotype	0.85
ALPHA-SYNUCLEIN	causes	protein	0.85
Inflammatory Processes	causes	process	0.85
MISFOLDED PROTEINS	causes	protein	0.85
STING	contributes_to	protein	0.85
phosphatidylethanolamine metabolism	contributes_to	pathway	0.85
DNA Damage-Induced Inflammation	contributes_to	process	0.85
Glial Cell Activation	causes	process	0.80
NAD+ depletion	causes	mechanism	0.80
Pesticides	causes	compound	0.75
Programmed DNA Breaks	contributes_to	process	0.75
MeCP2	causes	protein	0.70
Tau protein	causes	protein	0.70
3R/4R-tau ratio imbalance	causes	phenotype	0.70
pericyte loss	causes	mechanism	0.70
ER stress	causes	phenotype	0.70
mitochondrial_dysfunction	causes	phenotype	0.70
pericyte senescence	causes	process	0.70
MT-ND genes	causes	gene	0.70
damaged mitochondria	causes	process	0.70
41441843	must be considered in the context of	paper	0.60
Tau PTM modifications	associated_with	pathway	0.50

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (10)

Scientific analyses that reference this entity

Methodology challenge: dataset 'Allen Brain SEA-AD Single Cell Dataset' — evalua

neurodegeneration | 2026-04-28 | 7 hypotheses Top: 0.662

What blood-brain barrier permeability changes serve as early biomarkers for neur

neurodegeneration | 2026-04-26 | 8 hypotheses Top: 0.745

Does pericyte senescence drive BBB breakdown or result from neurodegeneration as

neurodegeneration | 2026-04-25 | 6 hypotheses Top: 0.720

scRNA-seq Processing and Cell Type Annotation of AD Brain

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.618

Cas13 gRNA Design for Silencing MAPT (Tau) Transcripts in Alzheimer's Disease

neurodegeneration | 2026-04-16 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (12)

Multi-agent debates referencing this entity

Methodology challenge: dataset 'Allen Brain SEA-AD Single Cell Dataset' — evalua

closed · Rounds: 4 · Score: 0.76 · 2026-04-28

What blood-brain barrier permeability changes serve as early biomarkers for neur

closed · Rounds: 4 · Score: 1.00 · 2026-04-26

Does pericyte senescence drive BBB breakdown or result from neurodegeneration as

closed · Rounds: 4 · Score: 0.68 · 2026-04-25

The core research question was never addressed due to missing literature content

closed · Rounds: 4 · Score: 0.30 · 2026-04-21

Can optimized Cas13 guide RNAs selectively silence pathogenic MAPT splice varian

closed · Rounds: 4 · Score: 0.70 · 2026-04-21

Can standardized scRNA-seq processing and automated annotation identify novel ce

closed · Rounds: 4 · Score: 0.70 · 2026-04-21

The debate highlighted that mitochondrial transfer could be therapeutic, but rai

closed · Rounds: 4 · Score: 0.50 · 2026-04-20

Does the hybrid DAM + interferon-response microglial population represent a nove

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

Is Cas13-based 4R-tau silencing feasible given collateral cleavage risks in post

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

The debate assumed static 5-hydroxymethylcytosine patterns in aging neurons are

closed · Rounds: 4 · Score: 0.95 · 2026-04-16

Related Research

Hypotheses and analyses mentioning Neuronal Dysfunction in their description or question text

No additional research found

Neuronal Dysfunction

Understanding Entity Pages

Pathway Diagram

Outgoing (2)

Incoming (33)

Targeting Hypotheses (0)

Mentioning Analyses (10)

Methodology challenge: dataset 'Allen Brain SEA-AD Single Cell Dataset' — evalua

What blood-brain barrier permeability changes serve as early biomarkers for neur

Does pericyte senescence drive BBB breakdown or result from neurodegeneration as

scRNA-seq Processing and Cell Type Annotation of AD Brain

Cas13 gRNA Design for Silencing MAPT (Tau) Transcripts in Alzheimer's Disease

Are age-related static epigenetic patterns pathogenic or protective compensatory

Do transferred mitochondria from diseased astrocytes carry pathological damage t

Which specific post-translational modifications distinguish pathological from ph

Can nanobodies achieve selective membrane penetration into tau-containing vesicl

Senolytic therapy for age-related neurodegeneration

Experiments (0)

Related Papers (0)

Debates (12)

Methodology challenge: dataset 'Allen Brain SEA-AD Single Cell Dataset' — evalua

What blood-brain barrier permeability changes serve as early biomarkers for neur

Does pericyte senescence drive BBB breakdown or result from neurodegeneration as

The core research question was never addressed due to missing literature content

Can optimized Cas13 guide RNAs selectively silence pathogenic MAPT splice varian

Can standardized scRNA-seq processing and automated annotation identify novel ce

The debate highlighted that mitochondrial transfer could be therapeutic, but rai

Does the hybrid DAM + interferon-response microglial population represent a nove

Is Cas13-based 4R-tau silencing feasible given collateral cleavage risks in post

The debate assumed static 5-hydroxymethylcytosine patterns in aging neurons are

Related Research